{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:09:35Z","timestamp":1790788175901,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP327387"],"award-info":[{"award-number":["MOP327387"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP13129"],"award-info":[{"award-number":["MOP13129"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to systematically describe the burden and distribution of white matter hyperintensities (WMH) and investigate correlations with neuropsychiatric symptoms in pathologically proven Alzheimer\u2019s disease (AD) and frontotemporal lobar degeneration (FTLD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Autopsy-confirmed cases were identified from the Sunnybrook Dementia Study, including 15 cases of AD and 58 cases of FTLD (22 FTLD-TDP cases; 10 FTLD-Tau [Pick\u2019s] cases; 11 FTLD-Tau Corticobasal Degeneration cases; and 15 FTLD-Tau Progressive Supranuclear Palsy cases). Healthy matched controls (\n                      <jats:italic>n<\/jats:italic>\n                      = 35) were included for comparison purposes. Data analyses included ANCOVA to compare the burden of WMH on antemortem brain MRI between groups, adjusted linear regression models to identify associations between WMH burden and neuropsychiatric symptoms, and image-guided pathology review of selected areas of WMH from each pathologic group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Burden and regional distribution of WMH differed significantly between neuropathological groups (\n                      <jats:italic>F<\/jats:italic>\n                      <jats:sub>5,77<\/jats:sub>\n                      = 2.67,\n                      <jats:italic>P\u2019<\/jats:italic>\n                      = 0.029), with the FTLD-TDP group having the highest mean volume globally (8032 \u00b1 8889 mm\n                      <jats:sup>3<\/jats:sup>\n                      ) and in frontal regions (4897 \u00b1 6163 mm\n                      <jats:sup>3<\/jats:sup>\n                      ). The AD group had the highest mean volume in occipital regions (468 \u00b1 420 mm\n                      <jats:sup>3<\/jats:sup>\n                      ). Total score on the Neuropsychiatric Inventory correlated with bilateral frontal WMH volume (\u03b2 = 0.330,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.006), depression correlated with bilateral occipital WMH volume (\u03b2 = 0.401,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), and apathy correlated with bilateral frontal WMH volume (\u03b2 = 0.311,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.009), all corrected for the false discovery rate. Image-guided neuropathological assessment of selected cases with the highest burden of WMH in each pathologic group revealed presence of severe gliosis, myelin pallor, and axonal loss, but with no distinguishing features indicative of the underlying proteinopathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that WMH are associated with neuropsychiatric manifestations in AD and FTLD and that WMH burden and regional distribution in neurodegenerative disorders differ according to the underlying neuropathological processes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00869-6","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T14:11:14Z","timestamp":1626185474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Philippe","family":"Desmarais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Rogaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald T.","family":"Stuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Masellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"issue":"4","key":"869_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","volume":"62","author":"CR Jack","year":"2004","unstructured":"Jack CR, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, et al. Comparison of different MRI brain atrophy, rate measures with clinical disease progression in AD. Neurology. 2004;62(4):591\u2013600. https:\/\/doi.org\/10.1212\/01.WNL.0000110315.26026.EF.","journal-title":"Neurology"},{"issue":"2","key":"869_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1212\/WNL.58.2.198","volume":"58","author":"HJ Rosen","year":"2002","unstructured":"Rosen HJ, Gorno-Tempini ML, Goldman WP, Perry RJ, Schuff N, Weiner M, et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology. 2002;58(2):198\u2013208. https:\/\/doi.org\/10.1212\/WNL.58.2.198.","journal-title":"Neurology"},{"issue":"24","key":"869_CR3","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1212\/WNL.0b013e318202038c","volume":"75","author":"JD Rohrer","year":"2010","unstructured":"Rohrer JD, Geser F, Zhou J, Gennatas ED, Sidhu M, Trojanowski JQ, et al. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology. 2010;75(24):2204\u201311. https:\/\/doi.org\/10.1212\/WNL.0b013e318202038c.","journal-title":"Neurology"},{"issue":"9","key":"869_CR4","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/brain\/awg196","volume":"126","author":"G Chetelat","year":"2003","unstructured":"Chetelat G, Desgranges B, de la Sayette V, Viader F, Berkouk K, Landeau B, et al. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain. 2003;126(9):1955\u201367. https:\/\/doi.org\/10.1093\/brain\/awg196.","journal-title":"Brain"},{"issue":"3","key":"869_CR5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3233\/JAD-170348","volume":"60","author":"E Finger","year":"2017","unstructured":"Finger E, Zhang J, Dickerson B, Bureau Y, Masellis. Disinhibition in Alzheimer\u2019s disease is associated with reduced right frontal pole cortical thickness. J Alzheimers Dis. 2017;60(3):1161\u201370. https:\/\/doi.org\/10.3233\/JAD-170348.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"869_CR6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1161\/01.STR.26.7.1171","volume":"26","author":"A Ylikoski","year":"1995","unstructured":"Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R. White-matter hyperintensities on MRI in the neurologically nondiseased elderly - analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke. 1995;26(7):1171\u20137. https:\/\/doi.org\/10.1161\/01.STR.26.7.1171.","journal-title":"Stroke"},{"issue":"1","key":"869_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1212\/01.wnl.0000191403.95453.6a","volume":"66","author":"ME Gurol","year":"2006","unstructured":"Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, et al. Plasma beta-amyloid and white matter lesions in AD, MCI and cerebral amyloid angiopathy. Neurology. 2006;66(1):23\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000191403.95453.6a.","journal-title":"Neurology"},{"issue":"4","key":"869_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jnen\/nlx009","volume":"76","author":"J Keith","year":"2017","unstructured":"Keith J, Gao F, Noor R, Kiss A, Balasubramaniam G, Au K, et al. Collagenosis of the deep medullary veins: an underrecognized pathologic correlate of white matter hyperintensities and periventricular infarction? J Neuropathol Exp Neurol. 2017;76(4):299\u2013312. https:\/\/doi.org\/10.1093\/jnen\/nlx009.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"869_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/alzrt279","volume":"6","author":"J Ramirez","year":"2014","unstructured":"Ramirez J, McNeely AA, Scott CJM, Stuss DT, Black SE. Subcortical hyperintensity volumetrics in Alzheimer\u2019s disease and normal elderly in the Sunnybrook Dementia Study: correlations with atrophy, executive function, mental processing speed, and verbal memory. Alzheimers Res Ther. 2014;6(4):49. https:\/\/doi.org\/10.1186\/alzrt279.","journal-title":"Alzheimers Res Ther"},{"issue":"17","key":"869_CR10","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1212\/WNL.0b013e318217e7c8","volume":"76","author":"EE Smith","year":"2011","unstructured":"Smith EE, Salar DH, Jeng J, McCreary CR, Fischl B, Schmahmann JD, et al. Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology. 2011;76(17):1492\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e318217e7c8.","journal-title":"Neurology"},{"issue":"7","key":"869_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jalz.2016.12.007","volume":"13","author":"SM Nestor","year":"2017","unstructured":"Nestor SM, Mi\u0161i\u0107 B, Ramirez J, Zhao J, Graham SJ, Verhoeff NPLG, et al. Small vessel disease is linked to disrupted structural network covariance in Alzheimer\u2019s disease. Alzheimers Dement. 2017;13(7):749\u201360. https:\/\/doi.org\/10.1016\/j.jalz.2016.12.007.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"869_CR12","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/archneurol.2012.2016","volume":"69","author":"Z Xi","year":"2012","unstructured":"Xi Z, Zinman L, Grinberg Y, Moreno D, Sato C, Bilbao JM, et al. Investigation of c9orf72 in 4 degenerative disorders. Arch Neurol. 2012;69(12):1583\u201390. https:\/\/doi.org\/10.1001\/archneurol.2012.2016.","journal-title":"Arch Neurol"},{"issue":"11","key":"869_CR13","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1093\/brain\/awl276","volume":"129","author":"M Masellis","year":"2006","unstructured":"Masellis M, Momeni P, Meschino W, Heffner R Jr, Elder J, Sato C, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain. 2006;129(11):3115\u201323. https:\/\/doi.org\/10.1093\/brain\/awl276.","journal-title":"Brain"},{"issue":"1","key":"869_CR14","doi-asserted-by":"publisher","first-page":"16032","DOI":"10.1038\/npjgenmed.2016.32","volume":"1","author":"SMK Farhan","year":"2016","unstructured":"Farhan SMK, Dilliot AA, Ghani M, Sato C, Liang E, Zhang M, et al. The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration. NPJ Genom Med. 2016;1(1):16032. https:\/\/doi.org\/10.1038\/npjgenmed.2016.32.","journal-title":"NPJ Genom Med"},{"issue":"4","key":"869_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"869_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, et al. Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium. Brain Pathol. 2008;18(4):484\u201396. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00147.x.","journal-title":"Brain Pathol"},{"issue":"1","key":"869_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8(1):1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"869_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012;123(1):1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3.","journal-title":"Acta Neuropathol"},{"key":"869_CR19","doi-asserted-by":"publisher","unstructured":"Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM, Consortium for Frontotemporal Lobar Degeneration Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007;114:5-22, 1, doi: https:\/\/doi.org\/10.1007\/s00401-007-0237-2.","DOI":"10.1007\/s00401-007-0237-2"},{"issue":"1","key":"869_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-008-0460-5","volume":"117","author":"IRA Mackenzie","year":"2009","unstructured":"Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009;117(1):15\u20138. https:\/\/doi.org\/10.1007\/s00401-008-0460-5.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"869_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IRA Mackenzie","year":"2011","unstructured":"Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122(1):111\u20133. https:\/\/doi.org\/10.1007\/s00401-011-0845-8.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"869_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/nan.12526","volume":"45","author":"M Neumann","year":"2019","unstructured":"Neumann M, Mackenzie IRA. Review: neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol Appl Neurobiol. 2019;45(1):19\u201340. https:\/\/doi.org\/10.1111\/nan.12526.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"869_CR23","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.STR.0000237236.88823.47","volume":"37","author":"V Hachinski","year":"2006","unstructured":"Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220\u201341. https:\/\/doi.org\/10.1161\/01.STR.0000237236.88823.47.","journal-title":"Stroke"},{"issue":"2","key":"869_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.neuroimage.2010.09.013","volume":"54","author":"J Ramirez","year":"2011","unstructured":"Ramirez J, Gibson E, Quddus A, Lobaugh NJ, Feinstein A, Levine B, et al. Lesion Explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. Neuroimage. 2011;54(2):963\u201373. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.09.013.","journal-title":"Neuroimage"},{"issue":"9","key":"869_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-014-0071-4","volume":"6","author":"MR Misch","year":"2014","unstructured":"Misch MR, Mitchell S, Francis PL, Sherborn K, Meradje K, McNeely AA, et al. Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography. Alzheimers Res Ther. 2014;6(9):71. https:\/\/doi.org\/10.1186\/s13195-014-0071-4.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"869_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"key":"869_CR27","volume-title":"Professional manual","author":"MS Dementia","year":"1988","unstructured":"Dementia MS, Scale R. Professional manual. Florida: Psychological Assessment Resources; 1988."},{"issue":"Issue 5, Supple","key":"869_CR28","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","volume":"48","author":"JL Cummings","year":"1997","unstructured":"Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(Issue 5, Supplement 6):S10\u20136. https:\/\/doi.org\/10.1212\/WNL.48.5_Suppl_6.10S.","journal-title":"Neurology"},{"issue":"12","key":"869_CR29","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/jamaneurol.2014.1316","volume":"71","author":"P Caroppo","year":"2014","unstructured":"Caroppo P, Le Ber I, Camuzat A, Clot F, Naccache L, Lamari F, et al. Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin. JAMA Neurol. 2014;71(12):1562\u20136. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1316.","journal-title":"JAMA Neurol"},{"key":"869_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.0000000000004393","volume":"89","author":"JM Papma","year":"2017","unstructured":"Papma JM, Jiskoot LC, Panman JL, Dopper EG, den Heijer T, Donker Kaat L, et al. Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion. Neurology. 2017;89:1\u20139.","journal-title":"Neurology"},{"key":"869_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nicl.2017.04.015","volume":"15","author":"CH Sudre","year":"2017","unstructured":"Sudre CH, Bocchetta M, Cash D, Thomas DL, Woolacott I, Dick KM, et al. White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort. NeuroImage Clin. 2017;15:171\u201380. https:\/\/doi.org\/10.1016\/j.nicl.2017.04.015.","journal-title":"NeuroImage Clin"},{"issue":"1","key":"869_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-2094-4-7","volume":"4","author":"Z Ahmed","year":"2007","unstructured":"Ahmed Z, Mackenzie IRA, Hutton ML, Dickson DW. Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation. 2007;4(1):7. https:\/\/doi.org\/10.1186\/1742-2094-4-7.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"869_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archneur.63.1.81","volume":"63","author":"AL Boxer","year":"2006","unstructured":"Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schaeur GF, Miller BL, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006;63(1):81\u20136. https:\/\/doi.org\/10.1001\/archneur.63.1.81.","journal-title":"Arch Neurol"},{"issue":"6","key":"869_CR34","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/brain\/awh508","volume":"128","author":"NJ Cordato","year":"2005","unstructured":"Cordato NJ, Duggins AJ, Halliday GM, Morris JGL, Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain. 2005;128(6):1259\u201366. https:\/\/doi.org\/10.1093\/brain\/awh508.","journal-title":"Brain"},{"issue":"11","key":"869_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00234-007-0265-6","volume":"49","author":"M Koyama","year":"2007","unstructured":"Koyama M, Yagishita A, Nakata Y, Hayashi M, Bandoh M, Mizutani T. Imaging of corticobasal degeneration syndrome. Neuroradiology. 2007;49(11):905\u201312. https:\/\/doi.org\/10.1007\/s00234-007-0265-6.","journal-title":"Neuroradiology"},{"issue":"suppl 1","key":"869_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000051183","volume":"9","author":"E Englund","year":"1998","unstructured":"Englund E. Neuropathology of white matter changes in Alzheimer\u2019s disease and vascular dementia. Dement Geriatr Cogn Disorder. 1998;9(suppl 1):6\u201312. https:\/\/doi.org\/10.1159\/000051183.","journal-title":"Dement Geriatr Cogn Disorder"},{"issue":"4","key":"869_CR37","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3233\/JAD-180017","volume":"63","author":"ML Alosco","year":"2018","unstructured":"Alosco ML, Sugarman MA, Besser LM, Tripodis Y, Martin B, Palmisano J, et al. A clinicopathological investigation of white matter hyperintensities and Alzheimer\u2019s disease neuropathology. J Alzheimers Dis. 2018;63(4):1347\u201360. https:\/\/doi.org\/10.3233\/JAD-180017.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"869_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40478-015-0240-0","volume":"3","author":"KE McAleese","year":"2015","unstructured":"McAleese KE, Firbank M, Dey M, Colloby SJ, Walker L, Johnson M, et al. Cortical tau load is associated with white matter hyperintensities. Acta Neuropathol Commun. 2015;3(1):60. https:\/\/doi.org\/10.1186\/s40478-015-0240-0.","journal-title":"Acta Neuropathol Commun"},{"issue":"13","key":"869_CR39","doi-asserted-by":"publisher","first-page":"e1743","DOI":"10.1212\/WNL.0000000000011638","volume":"96","author":"K Huynh","year":"2021","unstructured":"Huynh K, Piguet P, Kwok J, Dobson-Stone C, Halliday GM, Hodges JR, et al. Clinical and biological correlates of white matter hyperintensities in patients with behavioral-variant frontotemporal dementia and Alzheimer disease. Neurology. 2021;96(13):e1743\u201354. https:\/\/doi.org\/10.1212\/WNL.0000000000011638.","journal-title":"Neurology"},{"issue":"7","key":"869_CR40","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.neurobiolaging.2013.01.002","volume":"34","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Kang SJ, Kim C, Kim GH, Jeon S, Lee JM, et al. The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments. Neurobiol aging. 2013;34(7):1913\u201320. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.01.002.","journal-title":"Neurobiol aging"},{"issue":"3","key":"869_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1176\/jnp.2009.21.3.259","volume":"21","author":"SE Starkstein","year":"2009","unstructured":"Starkstein SE, Mizrahi R, Capizzano AA, Acion L, Brockman S, Power BD, et al. Neuroimaging correlates of apathy and depression in Alzheimer\u2019s disease. J Neuropsychiatry Clin Neurosci. 2009;21(3):259\u201365. https:\/\/doi.org\/10.1176\/jnp.2009.21.3.259.","journal-title":"J Neuropsychiatry Clin Neurosci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00869-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T14:13:46Z","timestamp":1626185626000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00869-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00869-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-125103\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Sunnybrook Research and Ethics board and all participants, or their caregivers when appropriate, provided written informed consent, in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Black reports grants and personal fees from Eli Lilly, grants and personal fees from Novartis, grants from GE Healthcare, grants from Biogen, grants from Genentech, grants from Optina, grants, and personal fees from Roche, outside the submitted work.Dr. Masellis reports grants from Canadian Institutes of Health Research, during the conduct of the study; other from Associate Editor, Current Pharmacogenomics and Personalized Medicine, personal fees from Bioscape Medical Imaging CRO, personal fees from GE Healthcare, personal fees from UCB, grants from Canadian Institutes of Health Research, grants from Early Researcher Award, Ministry of Economic Development and Innovation of Ontario, grants from Ontario Brain Institute, grants from Sunnybrook AFP Innovation Fund, grants from Alzheimer\u2019s Drug Discovery Foundation (ADDF), grants from Brain Canada, grants from Heart and Stroke Foundation Centre for Stroke Recovery, grants from Weston Brain Institute, personal fees from Novartis, personal fees from Henry Stewart Talks, other from Novartis, grants from Roche, grants from Washington University, grants from Teva, and others from Teva, outside the submitted work.The other authors report no disclosures relevant to the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}